We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Treatment satisfaction in patients with erectile dysfunction switching from prostaglandin E<sub>1</sub> intracavernosal injection therapy to oral sildenafil citrate.
- Authors
Montorsi, F.; Althof, S.E.; Sweeney, M.; Menchini-Fabris, F.; Sasso, F.; Giuliano, F.
- Abstract
Treatment satisfaction, subanalysed by demographic variables, was evaluated in patients switching from successful intracavernosal prostaglandin E1 (PGE1) therapy to oral sildenafil citrate. The validated Erectile Dysfunction Inventory of Treatment Satisfaction questionnaire was administered at the end of PGE1 therapy and after 12 weeks of sildenafil treatment in a multicentre, open-label study. Men with erectile dysfunction (n=176) who were switched from stable PGE1 therapy to sildenafil (25-100?mg) were equally satisfied with onset of action, duration of action, and confidence in ability to engage in sexual activity, but expressed greater overall treatment satisfaction with sildenafil (P<0.01), better ease of use (P<0.001), naturalness of erectile process (P<0.001), and intention to continue treatment (P<0.001). Partners (n=32) were overall more satisfied with sildenafil (P<0.05), and their responses correlated with patient satisfaction (r=0.68). Compared with PGE1 injection, these data suggest that patients may be less likely to discontinue taking sildenafil treatment for their erectile dysfunction.International Journal of Impotence Research (2003) 15, 444-449. doi:10.1038/sj.ijir.3901049
- Subjects
PROSTAGLANDIN E1; SILDENAFIL; IMPOTENCE
- Publication
International Journal of Impotence Research, 2003, Vol 15, Issue 6, p444
- ISSN
0955-9930
- Publication type
Article
- DOI
10.1038/sj.ijir.3901049